CHARLOTTESVILLE, Va., March 31, 2026--(BUSINESS WIRE)--LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization ...

Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that ...

In 2023, industry is witnessing a renaissance in viral vector characterization. Spurred by widespread biopharma investment to engineer a new wave of novel capsids and faced with newly launched QbD ...

Analytical methods in differential systems and vector fields combine classical techniques with modern computational approaches to elucidate the intricate dynamics of nonlinear systems. Researchers use ...

In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foundational role. From early research through to GMP ...

Analytical performance should lead method decisions, but optimization can still reduce solvent, energy, and waste provided ...

LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921 ...

Collaboration set to develop and implement high-throughput analytical methods in support of Vector BioPharma's CMC (chemistry, manufacturing and controls) development Project to accelerate the ...